Natrium-Iodid-Symporter (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Natrium-Iodid-Symporter" in German language version.

refsWebsite
Global rank German rank
4th place
7th place
2nd place
3rd place
5,673rd place
995th place
low place
low place
low place
6,940th place
610th place
521st place

doi.org

  • Kogai T, Sajid-Crockett S, Newmarch LS, Liu YY, Brent GA: Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells. In: J. Endocrinol. 199. Jahrgang, Nr. 2, November 2008, S. 243–52, doi:10.1677/JOE-08-0333, PMID 18762555.
  • Hingorani M, White CL, Zaidi S, et al: Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: implications for sodium iodide symporter gene therapy. In: Clin. Cancer Res. 14. Jahrgang, Nr. 15, August 2008, S. 4915–24, doi:10.1158/1078-0432.CCR-07-4049, PMID 18676766.
  • Tran N, Valentín-Blasini L, Blount BC, et al: Thyroid-stimulating hormone increases active transport of perchlorate into thyroid cells. In: Am. J. Physiol. Endocrinol. Metab. 294. Jahrgang, Nr. 4, April 2008, S. E802–6, doi:10.1152/ajpendo.00013.2008, PMID 18303123.
  • Terrovitis J, Kwok KF, Lautamäki R, et al: Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. In: J. Am. Coll. Cardiol. 52. Jahrgang, Nr. 20, November 2008, S. 1652–60, doi:10.1016/j.jacc.2008.06.051, PMID 18992656.
  • Willhauck MJ, Samani BR, Wolf I, et al: The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer. In: Eur. J. Nucl. Med. Mol. Imaging. 35. Jahrgang, Nr. 7, Juli 2008, S. 1272–81, doi:10.1007/s00259-008-0775-4, PMID 18404268.

elsevier.com

linkinghub.elsevier.com

  • Dadachova E, Carrasco N: The Na/I symporter (NIS): imaging and therapeutic applications. In: Semin Nucl Med. 34. Jahrgang, Nr. 1, Januar 2004, S. 23–31, PMID 14735456 (elsevier.com).

nih.gov

ncbi.nlm.nih.gov

  • Kogai T, Sajid-Crockett S, Newmarch LS, Liu YY, Brent GA: Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells. In: J. Endocrinol. 199. Jahrgang, Nr. 2, November 2008, S. 243–52, doi:10.1677/JOE-08-0333, PMID 18762555.
  • Hingorani M, White CL, Zaidi S, et al: Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: implications for sodium iodide symporter gene therapy. In: Clin. Cancer Res. 14. Jahrgang, Nr. 15, August 2008, S. 4915–24, doi:10.1158/1078-0432.CCR-07-4049, PMID 18676766.
  • Tran N, Valentín-Blasini L, Blount BC, et al: Thyroid-stimulating hormone increases active transport of perchlorate into thyroid cells. In: Am. J. Physiol. Endocrinol. Metab. 294. Jahrgang, Nr. 4, April 2008, S. E802–6, doi:10.1152/ajpendo.00013.2008, PMID 18303123.
  • Terrovitis J, Kwok KF, Lautamäki R, et al: Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. In: J. Am. Coll. Cardiol. 52. Jahrgang, Nr. 20, November 2008, S. 1652–60, doi:10.1016/j.jacc.2008.06.051, PMID 18992656.
  • Dadachova E, Carrasco N: The Na/I symporter (NIS): imaging and therapeutic applications. In: Semin Nucl Med. 34. Jahrgang, Nr. 1, Januar 2004, S. 23–31, PMID 14735456 (elsevier.com).
  • Willhauck MJ, Samani BR, Wolf I, et al: The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer. In: Eur. J. Nucl. Med. Mol. Imaging. 35. Jahrgang, Nr. 7, Juli 2008, S. 1272–81, doi:10.1007/s00259-008-0775-4, PMID 18404268.

reactome.org

tcdb.org

uniprot.org